Genomics|Update|Non Communicable Diseases ► CANCER

Genomics|Update|Non Communicable Diseases

Volume 34  Number 14  April 9-16, 2015

Cancer

Are women willing to change breast cancer screening guidelines?
Cohn W et al. Cancer Epidemiol. Biomarkers Prev. 2015 Apr 24(4) 765

Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer
Rebbeck TR, et al. JAMA. 2015;313(13):1347-1361

Concerns about cancer risk and experiences with genetic testing in a diverse population of patients with breast cancer
Jagsi R, et al. Journal of Clinical Oncology 2015 Apr 6

A third of breast cancer patients concerned about genetic risk, Medical Xpress, Apr 6

Decision making about contralateral prophylactic mastectomy among BRCA1/2 noncarriers with newly-diagnosed breast cancer: Examining cognitive, emotional, and sociodemographic influences.
Hamilton JG, et al. Cancer Epidemiol Biomarkers Prev. 2015 Apr;24(4):760.

Evaluating the clinical impact of a genomic classifier in prostate cancer using individualized decision analysis.
Lobo JM et al. PLoS ONE 2015 10(3) e0116866

Factors affecting informed decision-making in women with increased breast cancer risk or DCIS pursuing contralateral prophylactic mastectomy.
Valente J et al. Cancer Epidemiol. Biomarkers Prev. 2015 Apr 24(4) 761

Factors associated with guideline-recommended KRAS testing in colorectal cancer patients: A population-based study.
Charlton ME et al. Am. J. Clin. Oncol. 2015 Apr 1. 

Five years of cancer drug approvals
Mailankody S, et al. JAMA Oncol. 2015 Apr 2

Implementation and outcomes of telephone disclosure of clinical BRCA1/2 test results.
Patrick-Miller L et al. Patient Educ Couns 2013 Dec 93(3) 413-9

Participation of Korean families at high risk for hereditary breast and ovarian cancer in BRCA1/2 genetic testing.
Sun Y et al. Jpn. J. Clin. Oncol. 2015 Apr 2.

Patient feedback and early outcome data with a novel tiered-binned model for multiplex breast cancer susceptibility testing.
Bradbury AR et al. Genet. Med. 2015 Apr 2.

When to consider referral to a genetic counselor for lesser known cancer syndromes
Heydrich CE, et al. Contemporary Oncology 2015 Apr 5